7 completed, 2 terminated, 1 unknown, 1 withdrawn. 4 Not applicable, 4 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Unknown 1 |
| Phase 2 | 4 | Terminated 2, Completed 1, Withdrawn 1 |
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
Follow Rottapharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ElectroPoration In a Clinical Setting Electroporation with voltage amplitude of 40 V (corresponding to an electric field strength of 100 V/cm), Electroporation with voltage amplitude of 60 V (corresponding to an electric field strength of 150 V/cm) - Tolerance | Not applicable | Completed | University of Milano Bicocca | 24 | 2020-12-09 | 2021-04-21 |
| Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C Legalon® SIL (Silibinin), Pegylated interferon alfa2b, Ribavirin - Hepatitis C, Chronic | Phase 2 / Phase 3 | Withdrawn | Rottapharm | 2013-08-01 | 2015-03-05 | |
| Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome Armolipid Plus, Placebo - Metabolic Syndrome, Insulin-resistance | Not applicable | Completed | Rottapharm | 159 | 2013-04-01 | 2015-10-27 |
| Estromineral Serena Plus and Symptomatic Menopause Estromineral Serena Plus, Estromineral - Menopause | Not applicable | Unknown | Rottapharm | 300 | 2012-11-01 | 2012-11-21 |
| Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Sillymarin, Placebo - Non-alcoholic Fatty Liver Disease | Phase 2 | Completed | University of Malaya | 99 | 2012-06-01 | 2016-01-08 |
| Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients Silibinin (Legalon-SIL), Saline - Hepatitis C Virus Recurrence | Phase 2 | Terminated | Rottapharm | 20 | 2011-08-01 | 2015-03-05 |
| Legalon SIL for the Treatment of HCV Recurrence in Liver Transplanted Patients Silibinin, Placebo - HCV Recurrence After Liver Transplantation | Phase 2 | Terminated | Rottapharm | 14 | 2010-09-01 | 2012-02-17 |
| Armolipid Plus and Metabolic Syndrome Armolipid Plus - Metabolic Syndrome | Not applicable | Completed | Rottapharm | 66 | 2009-09-01 | 2010-09-02 |
| Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function Mixture of Berberine, Policosanol, Red Yeast, Placebo - Hyperlipidemia, Endothelial Dysfunction | Completed | Federico II University | 50 | 2007-07-01 | 2008-04-16 | |
| DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) dexloxiglumide - Irritable Bowel Syndrome | Phase 3 | Completed | Rottapharm | 2003-07-01 | 2008-05-14 | |
| Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis Glucosamine sulfate, Acetaminophen - Knee Osteoarthritis | Phase 3 | Completed | Rottapharm | 300 | 2000-05-01 | 2006-09-19 |
Metabolic Syndrome (2) · Coronavirus Infections (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Hot Flashes (1) · Hyperlipidemias (1) · Hypertrophy, Left Ventricular (1) · Insulin Resistance (1) · Irritable Bowel Syndrome (1) · Non-alcoholic Fatty Liver Disease (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1)
Silybin (3) · policosanol (2) · Acetaminophen (1) · Berberine (1) · Electroporation (1) · Folic Acid (1) · Glucosamine (1) · Lovastatin (1) · Ribavirin (1) · Silymarin (1) · Sodium Chloride (1) · astaxanthine (1) · coenzyme Q10 (1) · dexloxiglumide (1) · peginterferon alfa-2b (1)
Italy (6) · Egypt (1) · Malaysia (1) · Portugal (1) · Spain (1) · United Kingdom (1)
Serafino Fazio, MD (2) · Alfredo Di Leo, MD (1) · Gabriel Herrero-Beaumont, MD (1) · Gamal Esmat, MD (1) · Peter J Whorwell, MD FRCP (1) · Samer El-Kamary, MD (1) · Sanjiv Mahadeva, MD, MRCP (1) · Vincenzo De Leo, MD (1) · Xavier Forns, Dr (1)